Profile
Dmitri Bobilev is currently the Chief Medical Officer at Fusion Pharmaceuticals, Inc. Prior to his current position, he worked as the Head of Clinical Development and Vice President at Vedanta Biosciences, Inc. from 2018 to 2020.
He also held the position of Vice President and Head of Clinical Development at Checkmate Pharmaceuticals, Inc. Dr. Bobilev earned a doctorate degree from Omsk State Medical Academy.
Dmitri Bobilev active positions
| Companies | Position | Start |
|---|---|---|
| FUSN PHAR | Chief Tech/Sci/R&D Officer | 07/11/2022 |
Former positions of Dmitri Bobilev
| Companies | Position | End |
|---|---|---|
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Corporate Officer/Principal | 01/08/2020 |
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Dmitri Bobilev
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Fusion Pharmaceuticals, Inc.
Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Omsk State Medical Academy
Omsk State Medical Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Dmitri Bobilev
















